Aurinia Pharmaceuticals Inc. develops and commercializes therapies for autoimmune diseases, with a focus on addressing rare and serious conditions. The company emphasizes innovation and patient-centric solutions to improve health outcomes in underserved medical areas.
1993
Canada
201 - 500 employees
Biotechnology
$100M - 500M in revenue
N/A in profitability
Industry rank: 8 out of 251
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: 8 out of 251
Total electricity
Share of renewable electricity
Industry benchmark
CO2e per visit (g)
Industry benchmark
Total Annual
Revenue & EBITDA
($ B)
Margin as % of revenue
R&D as % of revenue
Analyst consensus vs actuals
($ B)
0.2
▲ 0.1%
0.2
▼ 0.3%
0.3
▲ 0.8%
0.5
2030Not available
Not available
Not available
Available
6 out of 12 incl. management
Not available
Not available
Available
Not available
Not available
Not available
Not available